Updated Date: Fri, 25 Sep 2020 00:00:00 EDT
Category: Uncategorized
Trump takes Regeneron’s experimental antibodies hours after COVID-19 diagnosis kblankenship Fri, 10/02/2020 – 17:32
For the first time, researchers at the Centre for Proton Therapy at the Paul Scherrer Institute PSI in […]
The Royal College of Obstetrics and Gynaecology (RCOG) and the campaigning group Five X More have developed guidance […]
FiercePharmaAsia—CStone-Pfizer deal; Gilead’s filgotinib nods; Takeda-Ovid epilepsy data aliu Fri, 10/02/2020 – 05:41
Pfizer CEO Bourla, ‘disappointed’ by COVID vaccine rhetoric, warns politics could threaten uptake esagonowsky Fri, 10/02/2020 – 09:18
Gilead’s Truvada faces Teva generics assault amid Descovy switching campaign kblankenship Fri, 10/02/2020 – 09:42
Moderna CEO says coronavirus vaccine won’t be ready for FDA till late November: FT esagonowsky Fri, 10/02/2020 – […]
Researchers have found that the drug tofacitinib, also called Xeljanz and approved by the FDA to treat rheumatoid […]
